Cargando…
Baricitinib Liposomes as a New Approach for the Treatment of Sjögren’s Syndrome
Sjögren’s syndrome is a chronic systemic autoimmune disease affecting from 0.2 to 3% of the general population. The current treatment for Sjögren’s syndrome is aimed at controlling symptoms such as dry eyes and xerostomia. Systemic therapy with glucocorticoids or immunosuppressants is also used. Bar...
Autores principales: | Garrós, Núria, Mallandrich, Mireia, Beirampour, Negar, Mohammadi, Roya, Domènech, Òscar, Rodríguez-Lagunas, Maria José, Clares, Beatriz, Colom, Helena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9505846/ https://www.ncbi.nlm.nih.gov/pubmed/36145642 http://dx.doi.org/10.3390/pharmaceutics14091895 |
Ejemplares similares
-
Baricitinib Lipid-Based Nanosystems as a Topical Alternative for Atopic Dermatitis Treatment
por: Garrós, Núria, et al.
Publicado: (2023) -
Assessing the Solubility of Baricitinib and Drug Uptake in Different Tissues Using Absorption and Fluorescence Spectroscopies
por: Mohammadi-Meyabadi, Roya, et al.
Publicado: (2022) -
HPV Lesions and Other Issues in the Oral Cavity Treatment and Removal without Pain
por: El Moussaoui, Salima, et al.
Publicado: (2021) -
Caspofungin-Loaded Formulations for Treating Ocular Infections Caused by Candida spp.
por: Pérez-González, Noelia, et al.
Publicado: (2023) -
Validation of an Ex Vivo Permeation Method for the Intestinal Permeability of Different BCS Drugs and Its Correlation with Caco-2 In Vitro Experiments
por: B. Sánchez, Aroha, et al.
Publicado: (2019)